Stanford University
Menlo Park, CA, United States
Dr. Baker is the Clinical Chief in the Division of Immunology and Rheumatology at Stanford University and the Co-Director of the Stanford Multidisciplinary Sarcoidosis Program. He received his bachelor's degree from Pomona College, his medical degree from Harvard Medical School, and his master's degree in Epidemiology and Clinical Research from Stanford University. He completed his Internal Medicine residency at the Massachusetts General Hospital and his Rheumatology fellowship at Stanford University. Dr. Baker has established a clinical research program that is focused on clinical trials, epidemiological studies, and bench-to-bedside translational research. He has designed and led investigator-initiated and industry sponsored clinical trials with a focus on sarcoidosis, IgG4-related disease, and Sjogren's syndrome. He also utilizes large databases to study osteoarthritis, with an interest in repurposing existing drugs for the treatment of osteoarthritis.
Sunday, November 12, 2023
2:30 PM – 2:45 PM PT
Disclosure(s): Beigene: Grant/Research Support (Ongoing); Eli Lilly: Grant/Research Support (Ongoing); Horizon Therapeutics: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing); Mobility Bio: Consultant (Ongoing); Nēsos: Advisor or Review Panel Member (Terminated, October 1, 2018), Consultant (Terminated, October 1, 2018); Roivant: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing); Sanofi: Grant/Research Support (Ongoing); Zenas Biopharma: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing)
Sunday, November 12, 2023
4:15 PM – 4:25 PM PT
Disclosure(s): Beigene: Grant/Research Support (Ongoing); Eli Lilly: Grant/Research Support (Ongoing); Horizon Therapeutics: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing); Mobility Bio: Consultant (Ongoing); Nēsos: Advisor or Review Panel Member (Terminated, October 1, 2018), Consultant (Terminated, October 1, 2018); Roivant: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing); Sanofi: Grant/Research Support (Ongoing); Zenas Biopharma: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing)
Sunday, November 12, 2023
4:30 PM – 4:40 PM PT
Disclosure(s): Beigene: Grant/Research Support (Ongoing); Eli Lilly: Grant/Research Support (Ongoing); Horizon Therapeutics: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing); Mobility Bio: Consultant (Ongoing); Nēsos: Advisor or Review Panel Member (Terminated, October 1, 2018), Consultant (Terminated, October 1, 2018); Roivant: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing); Sanofi: Grant/Research Support (Ongoing); Zenas Biopharma: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing)
Tuesday, November 14, 2023
7:35 AM – 7:45 AM PT
Disclosure(s): Beigene: Grant/Research Support (Ongoing); Eli Lilly: Grant/Research Support (Ongoing); Horizon Therapeutics: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing); Mobility Bio: Consultant (Ongoing); Nēsos: Advisor or Review Panel Member (Terminated, October 1, 2018), Consultant (Terminated, October 1, 2018); Roivant: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing); Sanofi: Grant/Research Support (Ongoing); Zenas Biopharma: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing)
